Skin cancer pill showing ‘remarkable’ results, say researchers
August 26th, 2010 - 1:29 pm ICT by ANILondon, August 26 (ANI): Researchers say that a pill that helps slow the spread of advanced skin cancer is showing ‘remarkable’ results in early trials.
The drug, PLX4032, works by inhibiting a ‘faulty’ gene that constantly activates a protein which drives cell division and hence tumour growth.
Of 48 patients treated in the American and Australian study who had the faulty ‘BRAF’ gene, 37 saw their tumours shrink significantly.
In three cases the patients’ tumours disappeared altogether.
As the BRAF gene is present in between 40 and 60 per cent of patients with the disease, the new drug could help thousands.
“We have seen many tumours shrink rapidly, and in some patients, quality of life improved dramatically,” the Telegraph quoted Dr Paul Chapman, lead researcher on the study, as saying.
“This is the beginning of personalised medicine in melanoma,” Chapman added.
A larger clinical trial is now underway to determine if that is the case.
The study has been published in the New England Journal of Medicine. (ANI)
- Skin cancer pill shrinks tumour in 80 percent cases - Aug 26, 2010
- New hope in the fight against melanoma - Dec 14, 2010
- 'Spectacular' treatment for skin cancer developed - Sep 24, 2009
- Pill to fight deadly skin cancer in sight - Jan 20, 2011
- Arthritis drug could help treat skin cancer - Mar 24, 2011
- Novel drug raises hope for patients with advanced melanoma - Jun 02, 2009
- 'Penicillin' breakthrough in cancer treatment? - Sep 15, 2010
- New pills shrink cancer tumours by half - Jul 24, 2010
- California scientists hail 'penicillin moment' in cancer treatment - Sep 15, 2010
- Zebrafish offers skin cancer clues - Apr 06, 2011
- Scientists complete whole-exome sequencing of skin cancer - Apr 16, 2011
- New skin cancer pills 'can shrink tumours by up to 50pc' - Jul 24, 2010
- Vitamin pill a day keeps cancer at bay! - Mar 03, 2012
- How melanoma tumours evade drug treatment - Nov 25, 2010
- Zebrafish model reveals skin cancer-promoting gene - Mar 24, 2011
Tags: advanced skin, braf, cancer pill, chapman lead, clinical trial, dr paul, england journal of medicine, faulty gene, journal of medicine, melanoma, new england, new england journal, new england journal of medicine, paul chapman, quality of life, remarkable results, researcher, skin cancer, telegraph, tumours